T.Man Pharmaceutical PCL (BKK:TMAN)
Thailand · Delayed Price · Currency is THB 10.80
-0.20 (-1.82%)
At close: Aug 10, 2026
T.Man Pharmaceutical PCL Financials Overview
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,561 | 2,526 | 2,226 | 1,980 | 2,025 | 1,263 |
Revenue Growth | 14.53% | 13.48% | 12.42% | -2.20% | 60.26% | 40.25% |
Gross Profit Gross Profit Growth | 1,192 | 1,188 | 1,093 | 976.84 | 1,101 | 402.08 |
Operating Income Operating Income Growth | 575.12 | 584.79 | 549.98 | 525.04 | 608.21 | 81.01 |
Net Income Net Income Growth | 515.79 | 523.07 | 450.7 | 431.09 | 472.52 | 56.39 |
Earnings Per Share EPS Growth | 1.30 | 1.31 | 1.31 | 1.56 | 1.89 | 0.78 |
EPS Growth | 8.80% | -0.35% | -16.14% | -17.29% | 142.02% | -12.98% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Trading Products Trading Products Growth | 417 | 336 | 47 | 30 | 21 | 12 |
Manufactured Products Under Own Brand Manufactured Products Under Own Brand Growth | 2,014 | 2,097 | 2,132 | 1,924 | 1,985 | 1,227 |
Manufactured Products Under Third Parties' Brand Manufactured Products Under Third Parties' Brand Growth | 111 | 73 | 34 | 15 | 10 | 21 |
Unallocated Other Income Unallocated Other Income Growth | 19 | 20 | 13 | 8 | - | - |
Total Total Growth | 2,561 | 2,526 | 2,226 | 1,980 | 2,017 | 1,260 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 915.74 | 751.62 | 798.39 | 348.04 | 307.17 | 22.19 |
Total Debt Total Debt Growth | 920.28 | 943.46 | 1,151 | 591.48 | 638.99 | 670.21 |
Net Cash (Debt) Net Cash Growth | -4.54 | -191.84 | -352.22 | -243.44 | -331.82 | -648.02 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.01 | -0.48 | -1.03 | -0.88 | -1.33 | -8.98 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 377.63 | 336.44 | 519.66 | 282.09 | 523.53 | 275.74 |
Capital Expenditures CapEx Growth | -297.59 | -226.44 | -173.95 | -219.95 | -234.52 | -79.25 |
Free Cash Flow Free Cash Flow Growth | 80.04 | 110 | 345.71 | 62.15 | 289.02 | 196.49 |
Free Cash Flow Growth | -76.50% | -68.18% | 456.28% | -78.50% | 47.09% | 52.52% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 46.55% | 47.02% | 49.12% | 49.33% | 54.38% | 31.83% |
Operating Margin | 22.46% | 23.15% | 24.71% | 26.52% | 30.04% | 6.41% |
Pretax Margin | 23.74% | 24.30% | 23.87% | 25.77% | 29.20% | 5.84% |
Profit Margin | 20.14% | 20.71% | 20.25% | 21.77% | 23.34% | 4.46% |
FCF Margin | 3.13% | 4.35% | 15.53% | 3.14% | 14.27% | 15.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.640 | 0.560 | 0.200 | 0.036 |
Dividend Per Share Growth | 0% | 180.00% | 455.56% | - |
Dividend Yield | 5.82% | 5.58% | 1.45% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.32 | 7.88 | 13.05 | - | - | - |
Forward PE | 8.36 | 8.08 | 11.42 | - | - | - |
P/FCF Ratio | 53.98 | 37.46 | 17.01 | - | - | - |
PS Ratio | 1.69 | 1.63 | 2.64 | - | - | - |